Jorge Luis Flores Anato1, Dimitra Panagiotoglou1, Zoë R Greenwald2, Claire Trottier3, Maliheh Vaziri3, Réjean Thomas3, Mathieu Maheu-Giroux4. 1. Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montréal, QC, Canada. 2. Clinique Médicale l'Actuel, Montréal, QC, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. 3. Clinique Médicale l'Actuel, Montréal, QC, Canada. 4. Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montréal, QC, Canada. Electronic address: mathieu.maheu-giroux@mcgill.ca.
Abstract
INTRODUCTION: Chemsex among gay, bisexual and other men who have sex with men (gbMSM) has raised public health concerns because of its association with sexual behaviours that can increase transmission of sexually transmitted infections, including HIV. Pre-exposure prophylaxis (PrEP) is highly effective at blocking HIV acquisition, addressing important prevention needs among individuals practicing chemsex. This study aims to improve our understanding of chemsex practices and PrEP trajectories of gbMSM and transgender women consulting for PrEP. METHODS: We used data from the PrEP cohort of Clinique médicale l'Actuel, a major sexual health clinic in Montréal. We describe the sociodemographic profile of clients consulting for PrEP, characterize chemsex and polysubstance use trends over time, and evaluate PrEP trajectories using Kaplan-Meier curves. RESULTS: Among 2923 clients who consulted for PrEP between 2013-2020 (2910 cisgender gbMSM, 6 transgender gbMSM, 7 transgender women), 24 % reported chemsex in the past year and 13 % reported polysubstance use. The most common chemsex substances were ecstasy (14 %), GHB (13 %), and cocaine (12 %). The proportion of clients reporting chemsex and polysubstance use decreased over time. In both the chemsex and no-chemsex group, 73 % of clients initiated PrEP. The median time to discontinuation was similar between the chemsex (6.5 months; 95 %CI: 5.3-7.2) and no-chemsex group (6.9 months; 95 %CI: 6.3-7.5). CONCLUSION: Chemsex is not a barrier to PrEP initiation or persistence. However, these results suggest a high prevalence of chemsex among gbMSM consulting for PrEP, highlighting the need for services addressing the intersection of sexual health and substance use for this population.
INTRODUCTION: Chemsex among gay, bisexual and other men who have sex with men (gbMSM) has raised public health concerns because of its association with sexual behaviours that can increase transmission of sexually transmitted infections, including HIV. Pre-exposure prophylaxis (PrEP) is highly effective at blocking HIV acquisition, addressing important prevention needs among individuals practicing chemsex. This study aims to improve our understanding of chemsex practices and PrEP trajectories of gbMSM and transgender women consulting for PrEP. METHODS: We used data from the PrEP cohort of Clinique médicale l'Actuel, a major sexual health clinic in Montréal. We describe the sociodemographic profile of clients consulting for PrEP, characterize chemsex and polysubstance use trends over time, and evaluate PrEP trajectories using Kaplan-Meier curves. RESULTS: Among 2923 clients who consulted for PrEP between 2013-2020 (2910 cisgender gbMSM, 6 transgender gbMSM, 7 transgender women), 24 % reported chemsex in the past year and 13 % reported polysubstance use. The most common chemsex substances were ecstasy (14 %), GHB (13 %), and cocaine (12 %). The proportion of clients reporting chemsex and polysubstance use decreased over time. In both the chemsex and no-chemsex group, 73 % of clients initiated PrEP. The median time to discontinuation was similar between the chemsex (6.5 months; 95 %CI: 5.3-7.2) and no-chemsex group (6.9 months; 95 %CI: 6.3-7.5). CONCLUSION: Chemsex is not a barrier to PrEP initiation or persistence. However, these results suggest a high prevalence of chemsex among gbMSM consulting for PrEP, highlighting the need for services addressing the intersection of sexual health and substance use for this population.
Authors: Lorena De La Mora; Ainoa Ugarte; Josep Mallolas; Montserrat Laguno; Maria Martínez-Rebollar; Elisa De Lazzari; David García-Hernández; Guillermo Font; Nicolás De Loredo; Estela Solbes; Laia Miquel; Jordi Blanch; Berta Torres; Josep Riera; Iván Chivite; Juan Ambrosioni; Alexy Inciarte; Ana González-Cordón; Esteban Martínez; José Luis Blanco Journal: AIDS Behav Date: 2022-06-22
Authors: Michael Viamonte; Delaram Ghanooni; John M Reynolds; Christian Grov; Adam W Carrico Journal: Curr HIV/AIDS Rep Date: 2022-06-14 Impact factor: 5.495
Authors: Emilia M Jalil; Thiago S Torres; Claudia C de A Pereira; Alessandro Farias; Jose D U Brito; Marcus Lacerda; Daila A R da Silva; Nickols Wallys; Gabriela Ribeiro; Joyce Gomes; Thiffany Odara; Ludymilla Santiago; Sophie Nouveau; Marcos Benedetti; Cristina Pimenta; Brenda Hoagland; Beatriz Grinsztejn; Valdilea G Veloso Journal: Int J Environ Res Public Health Date: 2022-02-02 Impact factor: 3.390
Authors: Curtis Chan; Benjamin R Bavinton; Garrett E Prestage; Timothy R Broady; Limin Mao; John Rule; Ben Wilcock; Martin Holt Journal: Arch Sex Behav Date: 2022-06-07
Authors: Paul A Shuper; Thepikaa Varatharajan; David J Kinitz; Dionne Gesink; Narges Joharchi; Isaac I Bogoch; Mona Loutfy; Jürgen Rehm Journal: BMC Public Health Date: 2022-10-07 Impact factor: 4.135